Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 5 patents granted in the last 365 days
The University of Utah is managing 3 pending office actions in the Biotechnology & Pharmaceuticals technology area. These actions are distributed across 3 distinct art units, reflecting a variety of specialized technical focuses within their biotech portfolio. There are 3 distinct examiners assigned to these cases, with each examiner handling a single action. This distribution across three separate art units suggests a decentralized prosecution process for the university's current applications.
STOCKTON, LAURA LYNNE is identified as the busiest examiner, currently holding 1 pending action. Because the 3 pending office actions are spread among 3 distinct examiners, the prosecution strategy must be adapted to three different sets of examiner expectations. The involvement of 3 distinct art units further indicates that the university's research spans multiple biological or pharmaceutical disciplines. Practitioners must coordinate their efforts across these different divisions, as there is no concentration of cases under STOCKTON, LAURA LYNNE or any other official. This profile shows a balanced distribution of active matters, where each of the 3 actions is subject to an independent review by a different examiner in a different art unit.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 1 (33%) |
| §112 only | 1 (33%) |
| Double-patenting + other | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| STOCKTON, LAURA LYNNE | 1 | 75.3% | +33.7% |
| STEPHENS, AMELIA CAROLE | 1 | 75.0% | +50.0% |
| WOITACH, JOSEPH T | 1 | 49.5% | +27.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17520037 | METHODS AND SYSTEMS FOR GENOME ANALYSIS | WOITACH, JOSEPH T | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18397180 | VACCINATION AGAINST FUNGAL EPITOPES TO PREVENT INFLAMMATORY BOWEL DISEASES | STEPHENS, AMELIA CAROLE | 2d overdue |
| 18725391 | ANTIMICROBIAL COMPOUNDS AND METHODS | STOCKTON, LAURA LYNNE | — |
| 17520037 | METHODS AND SYSTEMS FOR GENOME ANALYSIS | WOITACH, JOSEPH T | — |
| Art Unit | Apps |
|---|---|
| 1626 | 1 |
| 1645 | 1 |
| 1687 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18725391 | ANTIMICROBIAL COMPOUNDS AND METHODS | STOCKTON, LAURA LYNNE | 1626 | §112 | Non-Final OA | — | Pending | Jun 28, 2024 |
| 18397180 | VACCINATION AGAINST FUNGAL EPITOPES TO PREVENT INFLAMMATORY BOWEL DISEASES | STEPHENS, AMELIA CAROLE | 1645 | §103§112DP | Final Rejection | 2d overdue | Pending | Dec 27, 2023 |
| 17520037 | METHODS AND SYSTEMS FOR GENOME ANALYSIS | WOITACH, JOSEPH T | 1687 | §101 | Non-Final OA | — | Pending | Nov 05, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUniversity of Utah has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
Laura Lynne Stockton has the most, with 1 of University of Utah's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
